Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-R Christiaens

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 11, 2008
Clinicopathological features of inflammatory versus noninflammatory locally advanced nonmetastatic breast cancerB Brouwers, R Paridaens, J P Lobelle, et al.
Pathology Research International|January 22, 2011
Short-Term Prognostic Index for Breast Cancer: NPI or LpiV Van Belle, J Decock, W Hendrickx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patientsL Morales, D Timmerman, P Neven, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomyI S Fentiman, M-R Christiaens, R Paridaens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2013
Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancersO Brouckaert, A Schoneveld, C Truyers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancerH Wildiers, P Neven, M R Christiaens, et al.
Breast Cancer Research and Treatment|May 13, 2014
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMIA Lintermans, K Van Asten, H Wildiers, et al.
Breast Cancer Research and Treatment|May 13, 2011
Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patientsT Vandorpe, A Smeets, B Van Calster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutionsM Saad Ismail, W Wynendaele, J L E Aerts, et al.
Breast Cancer Research and Treatment|December 1, 2010
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAsA Smeets, A Daemen, I Vanden Bempt, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 11, 2008
Clinicopathological features of inflammatory versus noninflammatory locally advanced nonmetastatic breast cancerB Brouwers, R Paridaens, J P Lobelle, et al.
Pathology Research International|January 22, 2011
Short-Term Prognostic Index for Breast Cancer: NPI or LpiV Van Belle, J Decock, W Hendrickx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patientsL Morales, D Timmerman, P Neven, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomyI S Fentiman, M-R Christiaens, R Paridaens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2013
Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancersO Brouckaert, A Schoneveld, C Truyers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancerH Wildiers, P Neven, M R Christiaens, et al.
Breast Cancer Research and Treatment|May 13, 2014
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMIA Lintermans, K Van Asten, H Wildiers, et al.
Breast Cancer Research and Treatment|May 13, 2011
Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patientsT Vandorpe, A Smeets, B Van Calster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutionsM Saad Ismail, W Wynendaele, J L E Aerts, et al.
Breast Cancer Research and Treatment|December 1, 2010
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAsA Smeets, A Daemen, I Vanden Bempt, et al.
Pageof 5